TJ301

· I-Mab Biopharma HongKong Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TJ301, covering 2021-01-05 to 2021-01-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of TJ301 IV in Participants With Active Ulcerative Colitis [Phase 2]